Literature DB >> 22020939

Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1α-TWIST signaling networks in human breast cancer cells.

Inamul Haque1, Snigdha Banerjee, Smita Mehta, Archana De, Monami Majumder, Matthew S Mayo, Suman Kambhampati, Donald R Campbell, Sushanta K Banerjee.   

Abstract

MicroRNAs (miRNAs) are naturally occurring single-stranded RNA molecules that post-transcriptionally regulate the expression of target mRNA transcripts. Many of these target mRNA transcripts are involved in regulating processes commonly altered during tumorigenesis and metastatic growth. These include cell proliferation, differentiation, apoptosis, migration, and invasion. Among the several miRNAs, miRNA-10b (miR-10b) expression is increased in metastatic breast cancer cells and positively regulates cell migration and invasion through the suppression of the homeobox D10 (HOXD10) tumor suppressor signaling pathway. In breast metastatic cells, miR-10b expression is enhanced by a transcription factor TWIST1. We find that miR-10b expression in breast cancer cells can be suppressed by CCN5, and this CCN5 effect is mediated through the inhibition of TWIST1 expression. Moreover, CCN5-induced inhibition of TWIST1 expression is mediated through the translational inhibition/modification of hypoxia-inducible factor-1α via impeding JNK signaling pathway. Collectively, these studies suggest a novel regulatory pathway exists through which CCN5 exerts its anti-invasive function. On the basis of these findings, it is plausible that reactivation of CCN5 in miR-10b-positive invasive/metastatic breast cancers alone or in combination with current therapeutic regimens could provide a unique, alternative strategy to existing breast cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22020939      PMCID: PMC3234824          DOI: 10.1074/jbc.M111.284158

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Cancer: micromanagement of metastasis.

Authors:  Patricia S Steeg
Journal:  Nature       Date:  2007-10-11       Impact factor: 49.962

2.  Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation.

Authors:  R Zhang; L Averboukh; W Zhu; H Zhang; H Jo; P J Dempsey; R J Coffey; A B Pardee; P Liang
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

3.  WISP-2/CCN5 is involved as a novel signaling intermediate in phorbol ester-protein kinase Calpha-mediated breast tumor cell proliferation.

Authors:  Krishanu Sengupta; Snigdha Banerjee; Kakali Dhar; Neela K Saxena; Smita Mehta; Donald R Campbell; Sushanta K Banerjee
Journal:  Biochemistry       Date:  2006-09-05       Impact factor: 3.162

Review 4.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

5.  Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.

Authors:  S A Mehta; K W Christopherson; P Bhat-Nakshatri; R J Goulet; H E Broxmeyer; L Kopelovich; H Nakshatri
Journal:  Oncogene       Date:  2006-11-27       Impact factor: 9.867

6.  Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis.

Authors:  Jie Xiang; Ji Wu
Journal:  Curr Genomics       Date:  2010-04       Impact factor: 2.236

7.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

Authors:  Shuomin Zhu; Hailong Wu; Fangting Wu; Daotai Nie; Shijie Sheng; Yin-Yuan Mo
Journal:  Cell Res       Date:  2008-03       Impact factor: 25.617

8.  The global burden of cancer.

Authors:  D M Parkin
Journal:  Semin Cancer Biol       Date:  1998-08       Impact factor: 15.707

9.  CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells.

Authors:  Snigdha Banerjee; Gopal Dhar; Inamul Haque; Suman Kambhampati; Smita Mehta; Krishanu Sengupta; Ossama Tawfik; Teresa A Phillips; Sushanta K Banerjee
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

10.  MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.

Authors:  Yong-Xi Song; Zhen-Yu Yue; Zhen-Ning Wang; Ying-Ying Xu; Yang Luo; Hui-Mian Xu; Xue Zhang; Li Jiang; Cheng-Zhong Xing; Yong Zhang
Journal:  Mol Cancer       Date:  2011-01-04       Impact factor: 27.401

View more
  44 in total

Review 1.  Racial disparity in breast cancer: can it be mattered for prognosis and therapy.

Authors:  Vijayalaxmi Gupta; Inamul Haque; Jinia Chakraborty; Stephanie Graff; Snigdha Banerjee; Sushanta K Banerjee
Journal:  J Cell Commun Signal       Date:  2017-11-29       Impact factor: 5.782

2.  MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.

Authors:  Guiqi Wang; Jingfeng Gu; Yingchao Gao
Journal:  Tumour Biol       Date:  2016-08-04

Review 3.  Reciprocal regulations between miRNAs and HIF-1α in human cancers.

Authors:  Wanli Yang; Jiaojiao Ma; Wei Zhou; Bo Cao; Xin Zhou; Hongwei Zhang; Qingchuan Zhao; Liu Hong; Daiming Fan
Journal:  Cell Mol Life Sci       Date:  2018-10-13       Impact factor: 9.261

Review 4.  Protein PEGylation for cancer therapy: bench to bedside.

Authors:  Vijayalaxmi Gupta; Sneha Bhavanasi; Mohiuddin Quadir; Kevin Singh; Gaurav Ghosh; Kritin Vasamreddy; Arnab Ghosh; Teruna J Siahaan; Snigdha Banerjee; Sushanta K Banerjee
Journal:  J Cell Commun Signal       Date:  2018-11-29       Impact factor: 5.782

5.  Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition.

Authors:  Gargi Maity; Archana De; Amlan Das; Snigdha Banerjee; Sandipto Sarkar; Sushanta K Banerjee
Journal:  Lab Invest       Date:  2015-04-13       Impact factor: 5.662

6.  CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27(Kip1) via Skp2 and FOXO3a regulation.

Authors:  I Haque; S Banerjee; A De; G Maity; S Sarkar; M Majumdar; S S Jha; D McGragor; S K Banerjee
Journal:  Oncogene       Date:  2014-08-18       Impact factor: 9.867

Review 7.  Hypoxia-inducible factor 1 and breast cancer metastasis.

Authors:  Zhao-Ji Liu; Gregg L Semenza; Hua-Feng Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2015-01       Impact factor: 3.066

8.  Expression of the circulating and the tissue microRNAs after surgery, chemotherapy, and radiotherapy in mice mammary tumor.

Authors:  Sadaf Farsinejad; Mahdi Rahaie; Ali Mohammad Alizadeh; Mohammad Mir-Derikvand; Zohre Gheisary; Hassan Nosrati; Solmaz Khalighfard
Journal:  Tumour Biol       Date:  2016-08-26

Review 9.  Hypoxia: a master regulator of microRNA biogenesis and activity.

Authors:  Shriram Nallamshetty; Stephen Y Chan; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2013-05-24       Impact factor: 7.376

10.  MicroRNA-10b regulates epithelial-mesenchymal transition by modulating KLF4/Notch1/E-cadherin in cisplatin-resistant nasopharyngeal carcinoma cells.

Authors:  Pei Zhang; Haiyu Hong; Xiaojin Sun; Hao Jiang; Shiyin Ma; Surong Zhao; Mengxiao Zhang; Zhiwei Wang; Chenchen Jiang; Hao Liu
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.